Aminoacyl-tRNA synthetases and tumorigenesis: more than housekeeping

Over the past decade, the identification of cancer-associated factors has been a subject of primary interest not only for understanding the basic mechanisms of tumorigenesis but also for discovering the associated therapeutic targets. However, aminoacyl-tRNA synthetases (ARSs) have been overlooked, mostly because many assumed that they were simply 'housekeepers' that were involved in protein synthesis. Mammalian ARSs have evolved many additional domains that are not necessarily linked to their catalytic activities. With these domains, they interact with diverse regulatory factors. In addition, the expression of some ARSs is dynamically changed depending on various cellular types and stresses. This Analysis article addresses the potential pathophysiological implications of ARSs in tumorigenesis.

[1]  J. Kushner,et al.  Elevated Methionine-tRNA Synthetase Activity in Human Colon Cancer 1 , 1976, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[2]  J. Baker,et al.  Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. , 1991, The Journal of biological chemistry.

[3]  P. Familletti,et al.  Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms. , 1992, The Journal of biological chemistry.

[4]  D. Ron,et al.  CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. , 1992, Genes & development.

[5]  D. Cleveland,et al.  Evidence for instability of mRNAs containing AUUUA motifs mediated through translation-dependent assembly of a > 20S degradation complex. , 1992, Genes & development.

[6]  D. Levens,et al.  A sequence-specific, single-strand binding protein activates the far upstream element of c-myc and defines a new DNA-binding motif. , 1994, Genes & development.

[7]  R. Fleischmann,et al.  Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer , 1994, Nature.

[8]  O. Myklebost,et al.  The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas. , 1994, Cancer genetics and cytogenetics.

[9]  K. Kinzler,et al.  Analysis of the 5' region of PMS2 reveals heterogeneous transcripts and a novel overlapping gene. , 1995, Genomics.

[10]  A. Tolstrup,et al.  Transcriptional Regulation of the Interferon--inducible Tryptophanyl-tRNA Synthetase Includes Alternative Splicing (*) , 1995, The Journal of Biological Chemistry.

[11]  P. Meltzer,et al.  Characterization of the 12q13-15 amplicon in soft tissue tumors. , 1995, Cancer genetics and cytogenetics.

[12]  M. Mirande,et al.  The p18 component of the multisynthetase complex shares a protein motif with the β and γ subunits of eukaryotic elongation factor 1 , 1996 .

[13]  K. Turpaev,et al.  Alternative processing of the tryptophanyl-tRNA synthetase mRNA from interferon-treated human cells. , 1996, European journal of biochemistry.

[14]  David Levens,et al.  The Far Upstream Element-binding Proteins Comprise an Ancient Family of Single-strand DNA-binding Transactivators* , 1996, The Journal of Biological Chemistry.

[15]  P. Meltzer,et al.  Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. , 1996, Cancer research.

[16]  J. L. Palmer,et al.  Cytogenetic and molecular genetic analysis of a pediatric pleomorphic sarcoma reveals similarities to adult malignant fibrous histiocytoma. , 1997, Cancer genetics and cytogenetics.

[17]  Key‐Sun Kim,et al.  A Multifunctional Repeated Motif Is Present in Human Bifunctional tRNA Synthetase* , 1998, The Journal of Biological Chemistry.

[18]  K. Shiba,et al.  Precursor of Pro-apoptotic Cytokine Modulates Aminoacylation Activity of tRNA Synthetase* , 1999, The Journal of Biological Chemistry.

[19]  P. Schimmel,et al.  Two distinct cytokines released from a human aminoacyl-tRNA synthetase. , 1999, Science.

[20]  J. Rivera,et al.  Suppression of Microphthalmia Transcriptional Activity by Its Association with Protein Kinase C-interacting Protein 1 in Mast Cells* , 1999, The Journal of Biological Chemistry.

[21]  J. Ferrer,et al.  CHOP/GADD153 and methionyl-tRNA synthetase (MetRS) genes overlap in a conserved region that controls mRNA stability. , 1999, Biochemical and biophysical research communications.

[22]  P. Schimmel,et al.  Highly Differentiated Motifs Responsible for Two Cytokine Activities of a Split Human tRNA Synthetase* , 1999, The Journal of Biological Chemistry.

[23]  M. Siatecka,et al.  Macromolecular assemblage of aminoacyl-tRNA synthetases: identification of protein-protein interactions and characterization of a core protein. , 1999, Journal of molecular biology.

[24]  T. Tsuruo,et al.  ASK1 mediates apoptotic cell death induced by genotoxic stress , 1999, Oncogene.

[25]  A. McLennan.  Dinucleoside polyphosphates-friend or foe? , 2000, Pharmacology & therapeutics.

[26]  Sunghoon Kim,et al.  Nucleolar Localization of Human Methionyl–Trna Synthetase and Its Role in Ribosomal RNA Synthesis , 2000, The Journal of cell biology.

[27]  K. Ohkubo,et al.  Mitochondrial gene mutations in the tRNA(Leu(UUR)) region and diabetes: prevalence and clinical phenotypes in Japan. , 2001, Clinical chemistry.

[28]  E. Choi,et al.  Glutamine-dependent Antiapoptotic Interaction of Human Glutaminyl-tRNA Synthetase with Apoptosis Signal-regulating Kinase 1* , 2001, The Journal of Biological Chemistry.

[29]  Sunghoon Kim,et al.  A Cofactor of tRNA Synthetase, p43, Is Secreted to Up-regulate Proinflammatory Genes* , 2001, The Journal of Biological Chemistry.

[30]  A. Fersht,et al.  Rescuing the function of mutant p53 , 2001, Nature Reviews Cancer.

[31]  Albert-László Barabási,et al.  Statistical mechanics of complex networks , 2001, ArXiv.

[32]  D. McRee,et al.  Crystal structure of a human aminoacyl-tRNA synthetase cytokine , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  W. Wong,et al.  Transitive functional annotation by shortest-path analysis of gene expression data , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Sunghoon Kim,et al.  p38 is essential for the assembly and stability of macromolecular tRNA synthetase complex: Implications for its physiological significance , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Sunghoon Kim,et al.  Interaction of the C-terminal Domain of p43 and the α Subunit of ATP Synthase , 2002, The Journal of Biological Chemistry.

[36]  Sunghoon Kim,et al.  Dose-dependent Biphasic Activity of tRNA Synthetase-associating Factor, p43, in Angiogenesis* , 2002, The Journal of Biological Chemistry.

[37]  P. Schimmel,et al.  A human aminoacyl-tRNA synthetase as a regulator of angiogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  P. Schimmel,et al.  Induction of Angiogenesis by a Fragment of Human Tyrosyl-tRNA Synthetase* , 2002, The Journal of Biological Chemistry.

[39]  Yili Yang,et al.  TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2 , 2002, Nature.

[40]  R. Kaufman.  Orchestrating the unfolded protein response in health and disease. , 2002, The Journal of clinical investigation.

[41]  Sunghoon Kim,et al.  Downregulation of FUSE-binding protein and c-myc by tRNA synthetase cofactor p38 is required for lung cell differentiation , 2003, Nature Genetics.

[42]  Bong‐Jin Lee,et al.  Solution structure and p43 binding of the p38 leucine zipper motif: coiled‐coil interactions mediate the association between p38 and p43 , 2003, FEBS letters.

[43]  Joshua M. Stuart,et al.  A Gene-Coexpression Network for Global Discovery of Conserved Genetic Modules , 2003, Science.

[44]  P. Pandolfi,et al.  Does the ribosome translate cancer? , 2003, Nature Reviews Cancer.

[45]  E. Hirsch,et al.  The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. , 2003, Human molecular genetics.

[46]  A. Rosen,et al.  Anti-aminoacyl tRNA synthetase immune responses: insights into the pathogenesis of the idiopathic inflammatory myopathies , 2003, Current opinion in rheumatology.

[47]  K. Fischbeck,et al.  Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. , 2003, American journal of human genetics.

[48]  H. Nechushtan,et al.  The function of lysyl-tRNA synthetase and Ap4A as signaling regulators of MITF activity in FcepsilonRI-activated mast cells. , 2004, Immunity.

[49]  O. Nureki,et al.  A short peptide insertion crucial for angiostatic activity of human tryptophanyl-tRNA synthetase , 2004, Nature Structural &Molecular Biology.

[50]  Sunghoon Kim,et al.  Noncanonical Function of Glutamyl-Prolyl-tRNA Synthetase Gene-Specific Silencing of Translation , 2004, Cell.

[51]  L. Hendershot,et al.  The role of the unfolded protein response in tumour development: friend or foe? , 2004, Nature Reviews Cancer.

[52]  J. Kornhauser,et al.  PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylation , 2004, Proteomics.

[53]  Homin K. Lee,et al.  Coexpression analysis of human genes across many microarray data sets. , 2004, Genome research.

[54]  Sunghoon Kim,et al.  Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. Reader,et al.  VE-cadherin Links tRNA Synthetase Cytokine to Anti-angiogenic Function* , 2005, Journal of Biological Chemistry.

[56]  Sunghoon Kim,et al.  Functional expansion of aminoacyl-tRNA synthetases and their interacting factors: new perspectives on housekeepers. , 2005, Trends in biochemical sciences.

[57]  Hamid Bolouri,et al.  A data integration methodology for systems biology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[58]  Hongjun Song,et al.  Accumulation of the Authentic Parkin Substrate Aminoacyl-tRNA Synthetase Cofactor, p38/JTV-1, Leads to Catecholaminergic Cell Death , 2005, The Journal of Neuroscience.

[59]  Sunghoon Kim,et al.  The Haploinsufficient Tumor Suppressor p18 Upregulates p53 via Interactions with ATM/ATR , 2005, Cell.

[60]  A. Uitterlinden,et al.  Evidence that the mitochondrial leucyl tRNA synthetase (LARS2) gene represents a novel type 2 diabetes susceptibility gene. , 2005, Diabetes.

[61]  Falk Schreiber,et al.  Exploration of biological network centralities with CentiBiN , 2006, BMC Bioinformatics.

[62]  J. Thevelein,et al.  Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy , 2006, Nature Genetics.

[63]  Eugene Y. Kim,et al.  The Novel Cytokine p43 Induces IL-12 Production in Macrophages via NF-κB Activation, Leading to Enhanced IFN-γ Production in CD4+ T Cells1 , 2006, The Journal of Immunology.

[64]  Sunghoon Kim,et al.  Antitumor activity of the novel human cytokine AIMP1 in an in vivo tumor model. , 2006, Molecules and cells.

[65]  S. Ackerman,et al.  Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration , 2006, Nature.

[66]  Seung Yong Park,et al.  AIMP3 haploinsufficiency disrupts oncogene-induced p53 activation and genomic stability. , 2006, Cancer research.

[67]  Christie M. Orschell,et al.  Endothelial-monocyte-activating polypeptide II induces migration of endothelial progenitor cells via the chemokine receptor CXCR3. , 2006, Experimental hematology.

[68]  Sunghoon Kim,et al.  Hierarchical Network between the Components of the Multi-tRNA Synthetase Complex , 2006, Journal of Biological Chemistry.

[69]  A. Eggermont,et al.  Endothelial monocyte-activating polypeptide-II and its functions in (patho)physiological processes. , 2006, Cytokine & growth factor reviews.

[70]  A. Kornelyuk,et al.  Antitumor effect of endothelial monocyte-activating polypeptide-II on human prostate adenocarcinoma in mouse xenograft model. , 2007, Experimental oncology.

[71]  P. S. Ray,et al.  Macromolecular complexes as depots for releasable regulatory proteins. , 2007, Trends in biochemical sciences.

[72]  Helen E. Parkinson,et al.  ArrayExpress—a public database of microarray experiments and gene expression profiles , 2006, Nucleic Acids Res..

[73]  Sunghoon Kim,et al.  Aminoacyl tRNA synthetases and their connections to disease , 2008, Proceedings of the National Academy of Sciences.

[74]  Samuel Myllykangas,et al.  CanGEM: mining gene copy number changes in cancer , 2007, Nucleic Acids Res..

[75]  Jun Dong,et al.  Geometric Interpretation of Gene Coexpression Network Analysis , 2008, PLoS Comput. Biol..

[76]  Lynne Marshall,et al.  RETRACTED: Elevated tRNAi Met Synthesis Can Drive Cell Proliferation and Oncogenic Transformation , 2008, Cell.

[77]  Y. Chung,et al.  Implication of leucyl-tRNA synthetase 1 (LARS1) over-expression in growth and migration of lung cancer cells detected by siRNA targeted knock-down analysis , 2008, Experimental & Molecular Medicine.

[78]  Eugene Y. Kim,et al.  Gene transfer of AIMP1 and B7.1 into epitope-loaded, fibroblasts induces tumor-specific CTL immunity, and prolongs the survival period of tumor-bearing mice. , 2008, Vaccine.

[79]  M. Kapoor,et al.  Evidence for Annexin II-S100A10 Complex and Plasmin in Mobilization of Cytokine Activity of Human TrpRS* , 2008, Journal of Biological Chemistry.

[80]  Sunghoon Kim,et al.  AIMP2/p38, the scaffold for the multi-tRNA synthetase complex, responds to genotoxic stresses via p53 , 2008, Proceedings of the National Academy of Sciences.

[81]  David C. H. Yang,et al.  Lysyl-tRNA synthetase interacts with EF1alpha, aspartyl-tRNA synthetase and p38 in vitro. , 2008, Biochemical and biophysical research communications.

[82]  Eugene Y. Kim,et al.  AIMP1/p43 Protein Induces the Maturation of Bone Marrow-Derived Dendritic Cells with T Helper Type 1-Polarizing Ability1 , 2008, The Journal of Immunology.

[83]  Sunghoon Kim,et al.  Determination of Three-dimensional Structure and Residues of the Novel Tumor Suppressor AIMP3/p18 Required for the Interaction with ATM* , 2008, Journal of Biological Chemistry.

[84]  J. Reader,et al.  The novel fragment of tyrosyl tRNA synthetase, mini‐ TyrRS, is secreted to induce an angiogenic response in endothelial cells , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[85]  S. Varambally,et al.  Proteomic Interrogation of Androgen Action in Prostate Cancer Cells Reveals Roles of Aminoacyl tRNA Synthetases , 2009, PloS one.

[86]  Sunghoon Kim,et al.  Chapter 1: The physiological role of lysyl tRNA synthetase in the immune system. , 2009, Advances in immunology.

[87]  Sunghoon Kim,et al.  Multidirectional tumor-suppressive activity of AIMP2/p38 and the enhanced susceptibility of AIMP2 heterozygous mice to carcinogenesis. , 2009, Carcinogenesis.

[88]  K. Yao,et al.  Inactivation of LARS2, located at the commonly deleted region 3p21.3, by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. , 2009, Acta biochimica et biophysica Sinica.

[89]  M. Hatzoglou,et al.  A stress-responsive RNA switch regulates VEGF expression , 2008, Nature.

[90]  L. Påhlman,et al.  The Prognostic Significance of Tryptophanyl-tRNA Synthetase in Colorectal Cancer , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[91]  Dae Kim,et al.  AIMP2 promotes TNFα-dependent apoptosis via ubiquitin-mediated degradation of TRAF2 , 2009, Journal of Cell Science.

[92]  Sunghoon Kim,et al.  MSC p43 required for axonal development in motor neurons , 2009, Proceedings of the National Academy of Sciences of the United States of America.

[93]  R. Mukhopadhyay,et al.  The GAIT system: a gatekeeper of inflammatory gene expression. , 2009, Trends in biochemical sciences.

[94]  Dennis B. Troup,et al.  NCBI GEO: archive for high-throughput functional genomic data , 2008, Nucleic Acids Res..

[95]  N. Awasthi,et al.  Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy , 2011, Cancer Chemotherapy and Pharmacology.

[96]  Sunghoon Kim,et al.  Identification of gp96 as a Novel Target for Treatment of Autoimmune Disease in Mice , 2010, PloS one.

[97]  Sunghoon Kim,et al.  Aminoacyl‐tRNA synthetase–interacting multifunctional proteins (AIMPs): A triad for cellular homeostasis , 2010, IUBMB life.

[98]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[99]  P. Schimmel,et al.  New functions of aminoacyl-tRNA synthetases beyond translation , 2010, Nature Reviews Molecular Cell Biology.

[100]  N. Awasthi,et al.  Antitumor effects of EMAP II against pancreatic cancer through inhibition of fibronectin-dependent proliferation , 2010, Cancer biology & therapy.

[101]  S. Martinis,et al.  The balance between pre‐ and post‐transfer editing in tRNA synthetases , 2010, FEBS letters.

[102]  N. Yoo,et al.  Frameshift Mutation of MARS Gene Encoding an Aminoacyl-tRNA Synthetase in Gastric and Colorectal Carcinomas with Microsatellite Instability. , 2010, Gut and liver.

[103]  S. Formenti,et al.  Translational control in cancer , 2010, Nature Reviews Cancer.

[104]  O. Birk,et al.  Pelizaeus-Merzbacher-like disease caused by AIMP1/p43 homozygous mutation. , 2010, American journal of human genetics.

[105]  B. Kennedy,et al.  Downregulation of lamin A by tumor suppressor AIMP3/p18 leads to a progeroid phenotype in mice , 2010, Aging cell.

[106]  Sunghoon Kim,et al.  Antitumor activity and pharmacokinetic properties of ARS-interacting multi-functional protein 1 (AIMP1/p43). , 2010, Cancer letters.

[107]  E. Masliah,et al.  Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies* , 2010, The Journal of Biological Chemistry.

[108]  Baojie Li,et al.  Mdm2 links genotoxic stress and metabolism to p53 , 2010, Protein & Cell.

[109]  R. Hannan,et al.  Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth. , 2011, Cancer research.

[110]  Florian Gnad,et al.  PHOSIDA 2011: the posttranslational modification database , 2010, Nucleic Acids Res..

[111]  H. P. Kang,et al.  Cancer-Associated Splicing Variant of Tumor Suppressor AIMP2/p38: Pathological Implication in Tumorigenesis , 2011, PLoS genetics.

[112]  J. Jia,et al.  Phosphorylation of glutamyl-prolyl tRNA synthetase by cyclin-dependent kinase 5 dictates transcript-selective translational control , 2011, Proceedings of the National Academy of Sciences.

[113]  Yunhui Liu,et al.  Role of ATP synthase alpha subunit in low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood–tumor barrier , 2011, Journal of the Neurological Sciences.

[114]  D. Fisher,et al.  Dual roles of lineage restricted transcription factors , 2011, Transcription.

[115]  Robert J. White,et al.  Retraction Notice to: Elevated tRNAi Met Synthesis Can Drive Cell Proliferation and Oncogenic Transformation , 2012, Cell.